Literature DB >> 25921180

SIRT7 Exhibits Oncogenic Potential in Human Ovarian Cancer Cells.

Hong-Ling Wang1, Ren-Quan Lu, Su-Hong Xie, Hui Zheng, Xue-Mei Wen, Xiang Gao, Lin Guo.   

Abstract

BACKGROUND: Sirtuin7 (SIRT7) is a type of nicotinamide adenine dinucleotide oxidized form (NAD+)-dependent deacetylase and the least understood member of the sirtuins family; it is implicated in various processes, such as aging, DNA damage repair and cell signaling transduction. There is some evidence that SIRT7 may function as a tumor trigger for human malignancy. Here, we aimed to explore the biological function of SIRT7 in ovarian carcinoma cells and its potential mechanism.
MATERIALS AND METHODS: Expression of SIRT7 in ovarian cancer cell lines was detected by western blotting. Transduced cell lines with SIRT7 knockdown or overexpression were constructed. Cell viability, cologenic, apoptosis-associated and motility assays were performed to elucidate the biological function of SIRT7 in ovarian cancer cells.
RESULTS: SIRT7 demonstrated a higher level in ovarian cancer cell lines compared with normal cells. On the one hand, down-regulation of SIRT7 significantly reduced ovarian cancer cell growth, repressed colony formation and increased cancer cell apoptosis; on the other hand, up-regulation promoted the migration of cancer cells. Additionally, repression of SIRT7 also induced change in apoptosis-related molecules and subunits of the NF-κB family.
CONCLUSIONS: In the present study, our data indicated that SIRT7 might play a role of oncogene in ovarian malignancy and be a potential therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25921180     DOI: 10.7314/apjcp.2015.16.8.3573

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  25 in total

1.  SIRT7 Is Activated by DNA and Deacetylates Histone H3 in the Chromatin Context.

Authors:  Zhen Tong; Yi Wang; Xiaoyu Zhang; David D Kim; Sushabhan Sadhukhan; Quan Hao; Hening Lin
Journal:  ACS Chem Biol       Date:  2016-03-03       Impact factor: 5.100

2.  NAD metabolism in aging and cancer.

Authors:  John Wr Kincaid; Nathan A Berger
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-05

3.  A Click Chemistry Approach Reveals the Chromatin-Dependent Histone H3K36 Deacylase Nature of SIRT7.

Authors:  Wesley Wei Wang; Maria Angulo-Ibanez; Jie Lyu; Yadagiri Kurra; Zhen Tong; Bo Wu; Ling Zhang; Vangmayee Sharma; Jennifer Zhou; Hening Lin; Yi Qin Gao; Wei Li; Katrin F Chua; Wenshe Ray Liu
Journal:  J Am Chem Soc       Date:  2019-02-04       Impact factor: 15.419

4.  The sirtuin family in cancer.

Authors:  Luis Filipe Costa-Machado; Pablo J Fernandez-Marcos
Journal:  Cell Cycle       Date:  2019-07-25       Impact factor: 4.534

5.  CYP2E1-dependent upregulation of SIRT7 is response to alcohol mediated metastasis in hepatocellular carcinoma.

Authors:  Chen Zhang; Jinqiu Zhao; Jie Zhao; Bohao Liu; Wenbin Tang; Yi Liu; Wenxiang Huang; Steven A Weinman; Zhuan Li
Journal:  Cancer Gene Ther       Date:  2022-07-28       Impact factor: 5.854

6.  miR-125b suppresses the proliferation of hepatocellular carcinoma cells by targeting Sirtuin7.

Authors:  Lixin Zhao; Weixing Wang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

7.  Sirtuin 7 plays an oncogenic role in human osteosarcoma via downregulating CDC4 expression.

Authors:  Wang Wei; Zhang Xiao Jing; Zheng Ke; Pei Yi
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

Review 8.  Sirtuins Expression and Their Role in Retinal Diseases.

Authors:  Sankarathi Balaiya; Khaled K Abu-Amero; Altaf A Kondkar; Kakarla V Chalam
Journal:  Oxid Med Cell Longev       Date:  2017-01-19       Impact factor: 6.543

9.  Sirtuin 7 promotes colorectal carcinoma proliferation and invasion through the inhibition of E-cadherin.

Authors:  Zhigang Deng; Xingbiao Wang; Xuan Long; Wanzhong Liu; Chunhua Xiang; Feng Bao; Dong Wang
Journal:  Exp Ther Med       Date:  2017-12-22       Impact factor: 2.447

10.  Sirtuin 7: a new marker of aggressiveness in prostate cancer.

Authors:  Romain Haider; Fabienne Massa; Lisa Kaminski; Stephan Clavel; Zied Djabari; Guillaume Robert; Kathiane Laurent; Jean-François Michiels; Matthieu Durand; Jean-Ehrland Ricci; Jean-François Tanti; Frédéric Bost; Damien Ambrosetti
Journal:  Oncotarget       Date:  2017-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.